R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics

R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics

imedex

3 months
162 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME: https://naccme.com/program/7330 In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Richard R. Furman utilizes a case presentation to examine personalized management strategies for relapsed/refractory, high risk patients with CLL. © 2019 Imedex, an HMP Company
Up Next Autoplay